PCR Stock Overview
Power Corporation of Canada, an international management and holding company, offers financial services in North America, Europe, and Asia.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 2/6 |
Past Performance | 3/6 |
Financial Health | 4/6 |
Dividends | 6/6 |
Rewards
Risk Analysis
No risks detected for PCR from our risk checks.
Power Corporation of Canada Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$24.60 |
52 Week High | CA$27.20 |
52 Week Low | CA$22.00 |
Beta | 1.09 |
1 Month Change | -6.11% |
3 Month Change | -3.91% |
1 Year Change | 2.50% |
3 Year Change | 8.99% |
5 Year Change | 20.71% |
Change since IPO | 3.54% |
Recent News & Updates
Recent updates
Shareholder Returns
PCR | DE Insurance | DE Market | |
---|---|---|---|
7D | -0.8% | -0.2% | -1.5% |
1Y | 2.5% | 21.5% | 0.9% |
Return vs Industry: PCR underperformed the German Insurance industry which returned 21.8% over the past year.
Return vs Market: PCR exceeded the German Market which returned -0.4% over the past year.
Price Volatility
PCR volatility | |
---|---|
PCR Average Weekly Movement | 3.0% |
Insurance Industry Average Movement | 2.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PCR has not had significant price volatility in the past 3 months.
Volatility Over Time: PCR's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1925 | n/a | Jeff Orr | www.powercorporation.com |
Power Corporation of Canada, an international management and holding company, offers financial services in North America, Europe, and Asia. It operates through Lifeco, IGM Financial, and GBL segments. The company offers life, health and dental, disability, critical illness, and creditor insurance; accidental death and dismemberment; retirement savings and income and annuity products; and life assurance, pension, and investment products to individuals and small business owners.
Power Corporation of Canada Fundamentals Summary
PCR fundamental statistics | |
---|---|
Market cap | €16.16b |
Earnings (TTM) | €1.58b |
Revenue (TTM) | €22.24b |
10.2x
P/E Ratio0.7x
P/S RatioIs PCR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PCR income statement (TTM) | |
---|---|
Revenue | CA$32.60b |
Cost of Revenue | CA$17.25b |
Gross Profit | CA$15.35b |
Other Expenses | CA$13.03b |
Earnings | CA$2.32b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
Earnings per share (EPS) | 3.57 |
Gross Margin | 47.08% |
Net Profit Margin | 7.11% |
Debt/Equity Ratio | 49.0% |
How did PCR perform over the long term?
See historical performance and comparison